Parexel in the News
June 15, 2023 – For the twelfth consecutive year, Parexel has been recognized with CRO Leadership Awards. Parexel was recognized across all five categories – Capabilities, Compatibility, Expertise, Quality, and Reliability – for exceeding customer expectations in different customer segments. Parexel’s award categories are consistent with 2022, including recognition in one new area (Expertise – Small Pharma).
June 2, 2023 – For the second year in a row, Parexel has received a “silver” rating in the 2023 EcoVadis Sustainability Rating Program. Each year, EcoVadis, the world’s largest and most trusted provider of business sustainability ratings, measures companies on their environmental, social and ethnical performance based on international standards across four themes (environment, ethics, labor and human rights, sustainability procurement). A silver rating is awarded to organizations with a structured and proactive sustainability approach with strong reporting on KPIs and actions. Parexel has participated in the EcoVadis Sustainability Rating Program since 2014.
May 31, 2023 – Parexel has been rated the “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. Among the 34 CROs included in the survey, Parexel received the highest average rating across all 26 performance attributes evaluated.
March 21, 2023 – Amy McKee, M.D., Chief Medical Officer & Head of the Oncology Center of Excellence has been recognized as a 2023 Luminary by the Healthcare Businesswomen’s Association (HBA) for her service as a role model within our company, actively mentoring and sponsoring others, helping advance women’s careers and exhibiting dedication to the healthcare community.